Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
Inscinstech Raises RMB 150 Million in Series A+, B, and B+ Rounds
January 26, 2025
Company
Everest Medicines Outlines Strategic Plans for Expansion and Growth
January 26, 2025
Company
Zai Lab Appoints Dr. Rafael Amado as President of Cancer R&D
January 26, 2025
Company
Drug
Jiangxi Jemincare Gains FDA Approval for Clinical Trial of JYB1907 in Solid Tumors
January 26, 2025
Company
Drug
Mabwell Receives NMPA Approval for Clinical Trial of 9MW3011 in Rare Diseases
January 26, 2025
Company
Drug
Staidson’s Anti-C5a Monoclonal Antibody STSA-1002 Accepted for NMPA Review
January 26, 2025
Company
Deals
Guangdong Raynovent Biotech Secures RMB 370 Million in Series C Financing
January 26, 2025
Company
Hengrui Pharmaceuticals Appoints Dr. Jiang Ningjun as Deputy General Manager and CSO
January 26, 2025
Company
Drug
Junshi Biosciences’ CGRP Monoclonal Antibody JS010 Accepted for NMPA Review
January 26, 2025
Company
Drug
BeiGene’s Tislelizumab Receives NMPA Review for First-Line HCC Indication
January 26, 2025
Company
Deals
Immunohead Biotech Raises RMB 200 Million in Series A+ Financing Round
January 26, 2025
Company
Deals
Biocytogen and Hansoh Enter Antibody Collaboration and Licensing Agreement
January 26, 2025
1
2
…
1,058
1,059
1,060
1,061
1,062
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?